obesity drug news today glp-1 drugs Market Overview: GLP-1 Agonists and the Obesity Market New Guidelines on GLP-1 Drugs

Bisaga, A., Danysz, W

My dear sweet son

RYBELSUS (semaglutide) prescribing information

Similarly, the STEP-6 study 25 reported a 3% incidence of psychiatric events with semaglutide 2.4 mg, compared to 1% in the placebo group

PDGF signalling controls age-dependent proliferation in pancreatic beta-cells

Some studies have reported that depression caused by chronic stress disrupts the BDNFtropomyosin related kinase B (TrkB) receptor signaling pathway in the PFC and hippocampus, and ultimately contributes to impaired synaptic maturation, synaptic protein synthesis, and glutamate receptor cycling ( Therefore, because neurotransmitter imbalance contributes to depressive behaviors in patients with depression as described above, the appropriate modulation of neurotransmitters in the brain is key to treating depression ( Figure 2 )